Schrödinger, Inc. SDGR
Set alert
At close · Oct 30
After hours · Oct 30, 7:59 PM ET
- YTD
- +51.79%
- 1 year
- +32.65%
- Open
- 28.95
- Prev close
- 29.99
- Mkt cap
- 2.03B
- Vol
- 1.95M
- Avg vol
- 1.99M
- EPS
- -0.74
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 26.44
- High
- 29.44
- Forward P/E
- -20.10
- Beta
- 1.62
- Short ratio
- 3.16
- Inst. own
- 97.84%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 24.81
- 200-d avg
- 16.71
- 1y target
- 25.86
5D chart
Signals (109)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:00 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:25 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:25 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:55 PM | 2 days ago |
| RSI: Oversold | Oct 30, 12:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:30 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:05 AM | 2 days ago |
| SMA: Bearish | Oct 30, 10:50 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:45 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:05 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 3 days ago |
| RSI: Oversold | Oct 29, 3:00 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:30 PM | 3 days ago |
| SMA: Bullish | Oct 29, 1:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:20 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:40 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 11:20 AM | 3 days ago |
| SMA: Bullish | Oct 29, 11:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:20 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:15 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:45 AM | 3 days ago |
| SMA: Bearish | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 3:05 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:00 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:40 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:40 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:05 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:05 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 27, 3:55 PM | 5 days ago |
| RSI: Oversold | Oct 27, 3:45 PM | 5 days ago |
| RSI: Oversold | Oct 27, 3:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:50 PM | 5 days ago |
| RSI: Overbought | Oct 27, 1:45 PM | 5 days ago |
| RSI: Overbought | Oct 27, 1:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:55 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:40 AM | 5 days ago |
| RSI: Overbought | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:10 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:20 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 11:50 AM | 6 days ago |
| SMA: Bearish | Oct 26, 11:45 AM | 6 days ago |
| RSI: Overbought | Oct 26, 11:20 AM | 6 days ago |
| SMA: Bullish | Oct 26, 10:45 AM | 6 days ago |
| SMA: Bearish | Oct 26, 10:40 AM | 6 days ago |
News
4 days ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
4 days ago zacks.com
Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline
Schrodinger (SDGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 days ago businesswire.com
Schrödinger to Present at UBS Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference. The live presentation will…
6 days ago businesswire.com
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on October 21, 2026, the company granted restricted stock units (RSUs) with respect to 5,716 shares of the company's…
-
1 week ago benzinga.com
UBS Maintains Neutral on Schrodinger, Raises Price Target to $21
UBS analyst Kevin Caliendo maintains Schrodinger (NASDAQ:SDGR) with a Neutral and raises the price target from $19 to $21.
2 weeks ago defenseworld.net
Schrodinger, Inc. $SDGR Shares Newly Purchased by Counterpoint Mutual Funds LLC
Counterpoint Mutual Funds LLC purchased a new stake in shares of Schrodinger, Inc. (NASDAQ: SDGR) in the third quarter, according to its most recent filing with the Securities and Exchange…
-
2 weeks ago benzinga.com
Keybanc Maintains Overweight on Schrodinger, Raises Price Target to $32
Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and raises the price target from $20 to $32.
2 weeks ago businesswire.com
Schrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery Chemistry
NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Schrödinger, Inc. (Nasdaq: SDGR) today announced the publication of new research in Nature that reveals critical insights into the atomic-scale structure of…
-
2 weeks ago benzinga.com
TD Cowen Maintains Buy on Schrodinger, Raises Price Target to $31
TD Cowen analyst Brendan Smith maintains Schrodinger (NASDAQ:SDGR) with a Buy and raises the price target from $20 to $31.
-
2 weeks ago benzinga.com
BMO Capital Maintains Outperform on Schrodinger, Raises Price Target to $30
BMO Capital analyst Gary Nachman maintains Schrodinger (NASDAQ:SDGR) with a Outperform and raises the price target from $24 to $30.
2 weeks ago defenseworld.net
Reviewing Claritev (NYSE:CTEV) and Schrodinger (NASDAQ:SDGR)
Schrodinger (NASDAQ: SDGR - Get Free Report) and Claritev (NYSE: CTEV - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on…
2 weeks ago defenseworld.net
Analyzing Teladoc Health (NYSE:TDOC) & Schrodinger (NASDAQ:SDGR)
Teladoc Health (NYSE: TDOC - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses…
3 weeks ago gurufocus.com
Schrodinger Inc (SDGR) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 72/100
On October 09, 2026, Schrodinger Inc (SDGR) shares rose 3.4%, currently trading at $27.28. This price is within a 52-week range of $10.95 to $33.78, demonstrati
3 weeks ago zacks.com
Schrodinger (SDGR) Surges 7.6%: Is This an Indication of Further Gains?
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more…
1 month ago benzinga.com
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You
A look at the stocks that are owned by Cathie Wood's Ark Invest and Donald Trump.
1 month ago benzinga.com
Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday
U.S. stocks rose; Vicor jumped 13.5% on a new license, while Generac surged 19.6% on an Amazon deal. Securitize and biotech shares rallied.
1 month ago seekingalpha.com
Schrödinger: Company Creation Is Now The Real Drug Business
Schrödinger, Inc. has undergone significant changes, including pipeline cuts and a strategic pivot away from solo clinical development. Despite software growth deceleration and pipeline setbacks,…
1 month ago businesswire.com
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on September 13, 2026, the company granted restricted stock units (RSUs) with respect to 2,243 shares of the company's…
1 month ago seekingalpha.com
Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Schrödinger, Inc. (SDGR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
1 month ago zacks.com
Schrodinger (SDGR) Soars 12.1%: Is Further Upside Left in the Stock?
Schrodinger (SDGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more…
1 month ago gurufocus.com
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033PR NewswireAUSTIN, Texas, Sept. 14, 2026AUSTIN, Texas, Sept. 14, 2026 /PRNewswire/ -- USA News
-
1 month ago benzinga.com
Schrödinger Announces Formation Of Tectora, New Biotechnology Company; Tectora Secures $55M Series A Investment From NEA And RA Capital Management
Schrödinger, Inc. (NASDAQ:SDGR) today announced the formation of Tectora, a new biotechnology company it co-founded with New Enterprise Associates (NEA) and RA Capital Management, focused on…
1 month ago businesswire.com
Schrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation Programs
NEW YORK--(BUSINESS WIRE)---- $SDGR #AI--Schrödinger announced the formation of Tectora, a biotech it co-founded with NEA and RA Capital, focused on immunology and inflammation therapies.
1 month ago defenseworld.net
Jupiter Topco LLC Acquires Shares of 28,299 Schrodinger, Inc. $SDGR
Jupiter Topco LLC bought a new stake in shares of Schrodinger, Inc. (NASDAQ: SDGR) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
2 months ago businesswire.com
Schrödinger to Present at Morgan Stanley Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The…
2 months ago defenseworld.net
BlackRock Inc. Buys New Shares in Schrodinger, Inc. $SDGR
BlackRock Inc. purchased a new position in Schrodinger, Inc. (NASDAQ: SDGR) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange…
2 months ago zacks.com
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
RXRX, SDGR, RLAY and ABSI are using AI-powered platforms to transform drug discovery while advancing proprietary clinical pipelines.
2 months ago gurufocus.com
Schrodinger Inc (SDGR) Stock Down 4.8% -- Now Undervalued? GF Score: 73/100
On August 14, 2026, Schrodinger Inc (SDGR) shares fell 4.8% to $17.58, continuing a trend of volatility as the stock has fluctuated between a 52-week high of $2
-
3 months ago benzinga.com
Schrödinger Rolls Out Early Access Version Of Bunsen
Schrödinger, Inc. (Nasdaq: SDGR) today announced the launch of its early access version of Bunsen, its new agentic AI co-scientist that helps researchers understand scientific objectives, develop…
4 months ago benzinga.com
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A decline, signaling a shift in AI adoption.
-
5 months ago benzinga.com
Morgan Stanley Maintains Equal-Weight on Schrodinger, Lowers Price Target to $17
Morgan Stanley analyst Vikram Malhorta maintains Schrodinger (NASDAQ:SDGR) with a Equal-Weight and lowers the price target from $19 to $17.
-
5 months ago benzinga.com
Schrodinger Affirms FY2026 Sales Guidance of $273.000M-$293.000M vs $252.752M Est
Schrodinger (NASDAQ:SDGR) affirms FY2026 sales outlook from $273.000 million-$293.000 million to $273.000 million-$293.000 million vs $252.752 million estimate.
-
6 months ago benzinga.com
Schrodinger Q1 Adj. EPS $(0.63), Inline, Sales $58.587M Beat $48.002M Estimate
Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.63) per share which met the analyst consensus estimate. This is a 1.56 percent increase over losses of $(0.64) per share from the same…
-
6 months ago benzinga.com
Keybanc Maintains Overweight on Schrodinger, Lowers Price Target to $20
Keybanc analyst Brandon Nispel maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers the price target from $25 to $20.
-
7 months ago benzinga.com
UBS Maintains Neutral on Schrodinger, Lowers Price Target to $13
UBS analyst Michael Yee maintains Schrodinger (NASDAQ:SDGR) with a Neutral and lowers the price target from $18 to $13.
-
8 months ago benzinga.com
Reported earlier, Schrodinger Sees FY2026 Sales $273.000M-$293.000M vs $301.358M Est
Schrodinger (NASDAQ:SDGR) sees FY2026 sales of $273.000 million-$293.000 million vs $301.358 million analyst estimate.
-
8 months ago benzinga.com
Schrodinger Q4 Sales $87.200M Beat $83.396M Estimate
Schrodinger (NASDAQ:SDGR) reported quarterly sales of $87.200 million which beat the analyst consensus estimate of $83.396 million by 4.56 percent. This is a 1.25 percent decrease over sales of…
-
8 months ago benzinga.com
Earnings Scheduled For February 25, 2026
Earnings Scheduled For February 25, 2026
8 months ago benzinga.com
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1
Top 3 Health Care stocks That Could Lead To Your Biggest Gains In Q1
-
9 months ago benzinga.com
Schrödinger Reports 2025 Progress, Highlights Physics+AI Platform Growth, Strategic Collaborations And Proprietary Therapeutics; Outlines 2026 Priorities For Platform Scaling And Clinical Advancements
Schrödinger, Inc. (NASDAQ:SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its…
-
9 months ago benzinga.com
TD Cowen Maintains Buy on Schrodinger, Lowers Price Target to $24
TD Cowen analyst Brendan Smith maintains Schrodinger (NASDAQ:SDGR) with a Buy and lowers the price target from $33 to $24.
-
9 months ago benzinga.com
Keybanc Maintains Overweight on Schrodinger, Lowers Price Target to $25
Keybanc analyst Scott Schoenhaus maintains Schrodinger (NASDAQ:SDGR) with a Overweight and lowers the price target from $28 to $25.
-
9 months ago benzinga.com
UBS Initiates Coverage On Schrodinger with Neutral Rating, Announces Price Target of $18
UBS analyst Michael Yee initiates coverage on Schrodinger (NASDAQ:SDGR) with a Neutral rating and announces Price Target of $18.
-
10 months ago benzinga.com
B of A Securities Upgrades Schrodinger to Buy, Maintains Price Target to $24
B of A Securities analyst Michael Ryskin upgrades Schrodinger (NASDAQ:SDGR) from Neutral to Buy and maintains the price target from $24 to $24.
-
12 months ago benzinga.com
Schrodinger Affirms FY2025 Sales Guidance of $243.440M-$257.460M vs $249.717M Est
Schrodinger (NASDAQ:SDGR) affirms FY2025 sales outlook from $243.440 million-$257.460 million to $243.440 million-$257.460 million vs $249.717 million estimate.
-
12 months ago benzinga.com
Schrodinger Q3 Adj. EPS $(0.57) Beats $(0.71) Estimate, Sales $54.324M Beat $51.557M Estimate
Schrodinger (NASDAQ:SDGR) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(0.71) by 19.26 percent. This is a 34.48 percent increase over losses of $(0.87)…
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025